Skip to content

Yoga for depression in pregnant women: a randomized controlled trial

Yoga-based lifestyle intervention for Antenatal Depression (YOGA-D) - YOGA-D

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067176
Enrollment
50
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: Yoga-Sanskar intervention for antenatal depression: Yoga-Sanskar (YS) intervention for antenatal depression YS is a type of gentle, prenatal yoga-based intervention. It is a practice

Sponsors

DBT-Wellcome Trust India Alliance
Lead Sponsor
Pravara Institute of Medical Sciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult pregnant women above 18 years of age Gestational age between 12–26 weeks Singleton pregnancy Patient Health Questionnaire-9 (PHQ-9) score of 10 or more Planning to stay in the study area throughout study duration (approximately four months)

Exclusion criteria

Exclusion criteria: Pregnant women advised rest/restriction of physical activities/laborious tasks by their obstetrician due to medical/obstetric problems History of one or more spontaneous abortions History of cervical stitch/encirclage operation History of pre-term labor/premature rupture of members Receiving treatment for depression or any other mental health condition Presence of suicidal ideation (score of 3 on PHQ-9 item 9) History of hypertension, heart disease, diabetes (including gestational diabetes), respiratory disease, severe anemia, lower respiratory tract infection Inability to communicate in Marathi language Inability to attend in-person yoga sessions

Design outcomes

Primary

MeasureTime frame
We will assess the feasibility and acceptability of the Yoga-Sanskar (YS) intervention and the preliminary efficacy of the intervention on depression in pregnant women. Process data will inform the feasibility of the enrolment, engagement with the intervention, and completion of the intervention. The process indicators are as follows: 1.Number and proportion of eligible participants enrolled per week in the YS and the EUC arm. 2.Number and proportion of enrolled participants in the YS arm who attend the first session, three follow-up training sessions, and the final assessment session. 3.Number and proportion of enrolled participants in both arms who complete the follow-up assessment three months post-randomization. Depression during pregnancy is the primary outcome to assess the efficacy of the intervention. We will assess depression using a culturally adapted and validated Marathi version of PHQ-9. Timepoint: Baseline, three-months post-randomization, post-delivery

Secondary

MeasureTime frame
Anxiety Stress Quality of Life Minor ailments in pregnancy Experience of pregnancy Attitude Treatment Expectation Self-Efficacy Competence Awareness Satisfaction Timepoint: Baseline, three-months post-randomization, post-delivery

Countries

India

Contacts

Public ContactRahul Shidhaye

Pravara Institute of Medical Sciences

rahul.shidhaye@pmtpims.org00917748095634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026